한글목차

세계의 녹내장 치료제 시장은 2024년에 73억 3,000만 달러로 평가되었으며, 2030년까지 CAGR 6.57%로 성장하여 107억 4,000만 달러에 달할 것으로 예측됩니다.

세계 녹내장 치료제 시장은 안압을 낮추고 시신경 손상을 예방하여 녹내장 진단을 받은 환자의 시력을 유지하는 것을 목표로 하는 약리학적 및 외과적 개입을 포함합니다. 시장 성장을 뒷받침하는 주요 요인으로는 전 세계 녹내장 유병률의 증가와 고령 인구의 증가를 들 수 있습니다.

주요 시장 촉진요인

전 세계 노인 인구의 증가는 녹내장 치료제 시장에 큰 영향을 미치는 기본적인 인구통계학적 변화를 나타냅니다. 나이가 들수록 녹내장 발병 가능성이 크게 증가하기 때문에 이러한 인구통계학적 변화가 환자 수 증가의 주요 요인으로 작용하고 있습니다.

주요 시장 과제

환자들의 장기적인 약물 복용 계획 미준수는 세계 녹내장 치료제 시장 확대에 큰 걸림돌로 작용하고 있습니다. 녹내장 약물 치료의 효과는 안압을 효과적으로 낮추고 진행성 시신경 손상을 예방하기 위해 환자가 지속적으로 적시에 약을 복용하는 데 근본적으로 의존합니다.

주요 시장 동향

녹내장 진단 및 관리에 인공지능(AI)을 통합하는 것은 환자 치료의 정확성과 효율성을 높이는 혁신적인 추세입니다. AI 알고리즘은 복잡한 안과 영상 및 임상 데이터를 분석하여 질병의 조기 발견과 보다 정확한 진행 모니터링을 촉진하여 적시에 개입할 수 있도록 돕습니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 녹내장 치료제 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 치료법별(점안약, 내복약, 레이저 수술, 기존 수술)
  • 녹내장 유형별(개방우각, 폐색우각)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 녹내장 치료제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 녹내장 치료제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 녹내장 치료제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 녹내장 치료제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 녹내장 치료제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 녹내장 치료제 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Novartis AG
• Merck & Co., Inc.
• AbbVie, Inc.
• Bausch Health Companies, Inc.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Alcon, Inc.
• Inotek Pharmaceuticals Corporation

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Glaucoma Therapeutics Market , valued at USD 7.33 Billion in 2024, is projected to experience a CAGR of 6.57% to reach USD 10.74 Billion by 2030. The global glaucoma therapeutics market encompasses pharmacological and surgical interventions designed to reduce intraocular pressure and prevent optic nerve damage, thereby preserving vision in individuals diagnosed with glaucoma. Key drivers supporting market growth include the rising global prevalence of glaucoma and the expanding geriatric population.

Key Market Drivers

The increasing global geriatric population represents a fundamental demographic shift significantly influencing the glaucoma therapeutics market. As individuals age, their susceptibility to developing glaucoma rises substantially, making this demographic expansion a primary driver of increased patient volumes. Older age is a well-established risk factor for glaucoma onset and progression, directly translating to a greater need for diagnostic screenings and subsequent therapeutic interventions.

Key Market Challenges

Patient non-adherence to long-term medication regimens presents a substantial impediment to the expansion of the global glaucoma therapeutics market. The efficacy of pharmacological interventions for glaucoma is fundamentally dependent on consistent and timely patient compliance to effectively reduce intraocular pressure and avert progressive optic nerve damage. When individuals do not adhere to their prescribed treatment schedules, the disease often progresses unchecked, leading to a greater need for more advanced and often expensive surgical procedures or a shift to alternative, more complex drug therapies. This undermines the overall perceived value and effectiveness of current pharmaceutical offerings and disrupts the consistent demand for long-term medication supplies.

Key Market Trends

The integration of artificial intelligence in glaucoma diagnostics and management represents a transformative trend, enhancing the precision and efficiency of patient care. AI algorithms can analyze complex ophthalmic imaging and clinical data to facilitate earlier disease detection and more accurate progression monitoring, thereby enabling timely interventions.

Key Market Players

• Novartis AG
• Merck & Co., Inc.
• AbbVie, Inc.
• Bausch Health Companies, Inc.
• Teva Pharmaceutical Industries Ltd.
• Pfizer Inc.
• Alcon, Inc.
• Inotek Pharmaceuticals Corporation

Report Scope:

In this report, the Global Glaucoma Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Glaucoma Therapeutics Market , By Treatment Type:

• Eye drops
• Medication
• Laser Surgery
• Traditional Surgery

Glaucoma Therapeutics Market , By Glaucoma Type:

• Open angle
• Closed angle

Glaucoma Therapeutics Market , By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Glaucoma Therapeutics Market .

Available Customizations:

Global Glaucoma Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Glaucoma Therapeutics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment Type (Eye drops, Medication, Laser Surgery, Traditional Surgery)
  • 5.2.2. By Glaucoma Type (Open angle, Closed angle)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Glaucoma Therapeutics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment Type
  • 6.2.2. By Glaucoma Type
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Glaucoma Therapeutics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment Type
      • 6.3.1.2.2. By Glaucoma Type
  • 6.3.2. Canada Glaucoma Therapeutics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment Type
      • 6.3.2.2.2. By Glaucoma Type
  • 6.3.3. Mexico Glaucoma Therapeutics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment Type
      • 6.3.3.2.2. By Glaucoma Type

7. Europe Glaucoma Therapeutics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment Type
  • 7.2.2. By Glaucoma Type
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Glaucoma Therapeutics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment Type
      • 7.3.1.2.2. By Glaucoma Type
  • 7.3.2. France Glaucoma Therapeutics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment Type
      • 7.3.2.2.2. By Glaucoma Type
  • 7.3.3. United Kingdom Glaucoma Therapeutics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment Type
      • 7.3.3.2.2. By Glaucoma Type
  • 7.3.4. Italy Glaucoma Therapeutics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment Type
      • 7.3.4.2.2. By Glaucoma Type
  • 7.3.5. Spain Glaucoma Therapeutics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment Type
      • 7.3.5.2.2. By Glaucoma Type

8. Asia Pacific Glaucoma Therapeutics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment Type
  • 8.2.2. By Glaucoma Type
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Glaucoma Therapeutics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment Type
      • 8.3.1.2.2. By Glaucoma Type
  • 8.3.2. India Glaucoma Therapeutics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment Type
      • 8.3.2.2.2. By Glaucoma Type
  • 8.3.3. Japan Glaucoma Therapeutics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment Type
      • 8.3.3.2.2. By Glaucoma Type
  • 8.3.4. South Korea Glaucoma Therapeutics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment Type
      • 8.3.4.2.2. By Glaucoma Type
  • 8.3.5. Australia Glaucoma Therapeutics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment Type
      • 8.3.5.2.2. By Glaucoma Type

9. Middle East & Africa Glaucoma Therapeutics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment Type
  • 9.2.2. By Glaucoma Type
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Glaucoma Therapeutics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment Type
      • 9.3.1.2.2. By Glaucoma Type
  • 9.3.2. UAE Glaucoma Therapeutics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment Type
      • 9.3.2.2.2. By Glaucoma Type
  • 9.3.3. South Africa Glaucoma Therapeutics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment Type
      • 9.3.3.2.2. By Glaucoma Type

10. South America Glaucoma Therapeutics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment Type
  • 10.2.2. By Glaucoma Type
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Glaucoma Therapeutics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment Type
      • 10.3.1.2.2. By Glaucoma Type
  • 10.3.2. Colombia Glaucoma Therapeutics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment Type
      • 10.3.2.2.2. By Glaucoma Type
  • 10.3.3. Argentina Glaucoma Therapeutics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment Type
      • 10.3.3.2.2. By Glaucoma Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Glaucoma Therapeutics Market : SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Novartis AG
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Merck & Co., Inc.
• 15.3. AbbVie, Inc.
• 15.4. Bausch Health Companies, Inc.
• 15.5. Teva Pharmaceutical Industries Ltd.
• 15.6. Pfizer Inc.
• 15.7. Alcon, Inc.
• 15.8. Inotek Pharmaceuticals Corporation

16. Strategic Recommendations

17. About Us & Disclaimer